Local Institution - 0024 — London

Public research footprint of Local Institution - 0024, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Relapsed or Refractory Multiple Myeloma · Non-obstructive Hypertrophic Cardiomyopathy · Hepatocellular Carcinoma

Recently updated registry entries

NCT03383458 — A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk… (Active Not Recruiting)
NCT03486873 — Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who… (Recruiting)
NCT02632409 — An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Local Institution - 0024?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.